Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Flapless Approach With and Without Enamel Matrix Derivatives in the Regenerative Treatment of Intrabony Defects: a Randomized Controlled Clinical Trial

NCT05456555 is registered in ClinicalTrials.gov with University of Turin, Italy as lead sponsor.

NCT NCT05456555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05456555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Flapless Approach With and Without Enamel Matrix Derivatives in the Regenerative Treatment of Intrabony Defects: a Randomized Controlled Clinical Trial
Lead sponsor
University of Turin, Italy
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
December 15, 2023
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrabony periodontal defect, periodontitis, adult